Financial statements Mar2Pharma

Balance sheet of Mar2Pharma

Company age:
Age:
15 y. 1 m. 12 d.
Share capital:
Share capital:
5 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of MAR2PHARMA

Year
2018
2019
2020
Total assets 593 819,43 481 645,13 369 768,41
A. Fixed assets 455 689,45 343 077,85 230 813,03
B. Current assets 138 129,98 138 567,28 138 955,38
C. Share capital contributions (basic funds) - - -
D. Own shares (stocks) - - -
Total liabilities 593 819,43 481 645,13 369 768,41
A. Equity 231 174,19 115 021,39 876,67
B. Liabilities and provisions for liabilities 362 645,24 366 623,74 368 891,74
I. Long-term liabilities 268 021,34 268 021,34 268 021,34
II. Short-term liabilities 94 623,90 98 602,40 100 870,40
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.